Abstract
Anabolic androgenic steroids (AAS) are often misused by adolescents and athletes. Their effects vary according to chemical structure and metabolism, route of administration, and AAS regimen. In this study, adult C57Bl/6 male mice were systemically exposed to testosterone propionate (TP), nandrolone or 17α-methyltestosterone (17α-meT), type I, type II and type III AAS, respectively, in order to determine the hedonic or aversive properties of each drug. For this purpose, the conditioned place preference (CPP) test was employed at three different AAS doses (0.075, 0.75 and 7.5 mg/kg). Other behavioral domains monitored were light-dark transitions (side changes) and general activity. TP shifted place preference at all doses tested, and nandrolone shifted place preference at 0.75 and 7.5 mg/kg, but not at 0.075 mg/kg, the lower dose tested. Conversely, mice receiving 17α-meT did not show alteration in the preference score. The lower dose of nandrolone did modify exploratory-based anxiety showing a decrease in light-dark transitions if compared to vehicle-treated animals, while mice treated with TP or 17α-meT were not affected. Our data suggest that when studying hedonic and rewarding properties of synthetic androgens, distinction has to be made based on type of AAS and metabolism.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 122-127 |
| Number of pages | 6 |
| Journal | Drug and Alcohol Dependence |
| Volume | 100 |
| Issue number | 1-2 |
| DOIs | |
| State | Published - Feb 1 2009 |
Funding
Role of the Funding Source: This research was made possible by Grant Number P20RR016470 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) to J.L. Barreto-Estrada. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the NCRR or NIH. Other support provided by MBRS-RISE at UPR-MSC (GM61838) to O. Figueroa, Beatriz Cruz and R. García-Sosa, MBRS-RISE at UNE (5R25-GM066250) to J. Parrilla-Carrero and Paul Brito-Vargas, NIH-MRISP (MH048190) to A. Lugo, and RCMI (G12RR030551)-UPRMSC. The NIH-NCRR had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.
Keywords
- Anabolic androgenic steroids
- Conditioned place preference
- Mice
- Reward
ASJC Scopus subject areas
- Psychiatry and Mental health
- Pharmacology (medical)
- Toxicology
- Pharmacology